Clinical Trial Detail

NCT ID NCT02399943
Title A Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Advanced Colorectal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Health Network, Toronto
Indications

colorectal cancer

Therapies

Panitumumab + Trametinib

Age Groups: adult

No variant requirements are available.